NCT05758194Completed
Mitigating Post-Op RV Dysfunction After LVAD Implantation
Protective Strategies to Mitigate Post-Operative Right Ventricular (PV) Dysfunction After Centrifugal Flow Durable Left Ventricular Assist Device (LVAD) Implantation
Source: ClinicalTrials.gov · Last updated 16 Oct 2025
Brief summary (registry, in English)
This project evaluates right ventricle (RV) protective strategies after left ventricular assist device (LVAD) implantation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 24 Feb 2023
- Start date
- 22 Mar 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- University of Chicago
- Diseases
- Heart failure
- NCT number
- NCT05758194
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 22 Mar 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with RV implantable cardiac device (ICD)/pacemaker lead who are pacemaker-dependent
Other
- Patients with pre-operative right ventricular mechanical circulatory support or having high likelihood of requiring right ventricular mechanical circulatory support.
- Pregnant patients
Who the study is looking for
- Age ≥ 18 years
- Undergoing durable LVAD implantation without plan for perioperative right ventricular mechanical circulatory support
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.